After adjusting the medication, we reinitiated the diagnostic process for primary aldosteronism; during this time, the patient exhibited a significant decrease in renin and an elevated ARR, and both captopril and saline infusion tests confirmed autonomous aldosterone secretion, establishing a diagnosis of primary hyperaldosteronism. This evidence concerns the gene REN and primary aldosteronism.